|
Real-time Estimate
Tradegate
11:39:07 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 79.30 EUR | +0.25% |
|
+0.38% | +24.74% |
| 08-27 | Orion launches share buyback for incentive program | FW |
| 08-10 | Orion License Partner Tenax's Pulmonary Hypertension Drug Fails to Improve Walk Distance in Late-stage Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORION OYJ | Other Pharmaceuticals | +0.44% | +0.38% | +24.74% | +17.63% | +129.94% | 12.93B |  |  | |
- Stock Market
- Stocks
- ORNBV Stock
- Charts Orion Oyj
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
